JPMORGAN CHASE & CO - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 1 filers reported holding IMMUNOMEDICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$96,768,000
+92.2%
1,135,108
-20.1%
0.02%
+60.0%
Q2 2020$50,337,000
+750.4%
1,420,349
+223.5%
0.01%
+900.0%
Q1 2020$5,919,000
-52.7%
439,076
-25.8%
0.00%
-50.0%
Q4 2019$12,513,000
+110.9%
591,424
+32.2%
0.00%
+100.0%
Q3 2019$5,933,000
-12.6%
447,459
-8.7%
0.00%0.0%
Q2 2019$6,790,000
-16.7%
490,343
+15.6%
0.00%
-50.0%
Q1 2019$8,149,000
+1049.4%
424,208
+753.6%
0.00%
Q4 2018$709,000
-20.9%
49,698
+15.5%
0.00%
Q3 2018$896,000
+10.6%
43,025
+25.8%
0.00%
Q2 2018$810,000
+139.6%
34,214
+48.2%
0.00%
Q1 2018$338,000
-5.1%
23,091
+4.7%
0.00%
Q4 2017$356,000
+17700.0%
22,052
+2677.3%
0.00%
Q2 2016$2,0000.0%7940.0%0.00%
Q1 2016$2,000
-60.0%
794
-47.9%
0.00%
Q4 2015$5,000
-95.8%
1,523
-92.0%
0.00%
Q3 2013$118,000
+13.5%
19,071
-0.5%
0.00%
Q2 2013$104,00019,1580.00%
Other shareholders

There were no reported owners of IMMUNOMEDICS INC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of IMMUNOMEDICS INC shareholders